Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bisphosphonates and bone quality].

Takami Miki1, Hiroshi Naka

  • 1Department of Geriartic Medicine, Graduate School of Medicine, Osaka City University.

Clinical Calcium
|June 3, 2005
PubMed
Summary

New drugs modestly increase bone density and prevent fractures like bisphosphonates. Research focuses on bone quality, with new imaging techniques expected to improve clinical evaluation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Catalyst Deuteration on the Reactivity of Chiral Phase-Transfer Organocatalysts.

Chemistry (Weinheim an der Bergstrasse, Germany)·2023
Same author

Iridium-catalyzed α-selective deuteration of alcohols.

Chemical science·2022
Same author

Preparation of a platinum nanoparticle catalyst located near photocatalyst titanium oxide and its catalytic activity to convert benzyl alcohols to the corresponding ethers.

RSC advances·2022
Same author

Transcriptional Induction of Cystathionine γ-Lyase, a Reactive Sulfur-Producing Enzyme, by Copper Diethyldithiocarbamate in Cultured Vascular Endothelial Cells.

International journal of molecular sciences·2020
Same author

Bazedoxifene improves renal function and increases renal phosphate excretion in patients with postmenopausal osteoporosis.

Journal of bone and mineral metabolism·2020
Same author

Executive summary of the Japan Osteoporosis Society Guide for the Use of Bone Turnover Markers in the Diagnosis and Treatment of Osteoporosis (2018 Edition).

Clinica chimica acta; international journal of clinical chemistry·2019

Area of Science:

  • Orthopedics and Bone Metabolism
  • Pharmacology
  • Medical Imaging

Context:

  • Current bisphosphonate treatments for fracture prevention are effective but their impact on bone quality is not fully understood.
  • Clinical evaluation of bone quality is limited, relying mainly on metabolic markers.
  • Emerging drugs offer fracture prevention comparable to bisphosphonates, necessitating a focus on bone quality assessment.

Purpose:

  • To explore the significance of bone quality in the context of new fracture prevention drugs.
  • To review current and emerging modalities for evaluating bone quality.
  • To highlight the limitations of existing clinical methods for assessing bone quality.

Summary:

  • Drugs that modestly increase bone mineral density and prevent fractures comparable to bisphosphonates are in clinical use.
  • Advanced imaging techniques like micro CT and Fourier transform infrared imaging spectroscopy have not revealed bone quality issues in bisphosphonate treatment.
  • Clinical assessment of bone quality remains limited, with few methods available beyond metabolic markers.

Impact:

  • Advances in imaging technologies such as low-dose CT, sensitive MRI, and ultrasonography are anticipated to enable better clinical evaluation of bone quality.
  • Improved bone quality assessment will support the development and clinical application of novel fracture prevention therapies.
  • This research underscores the need for enhanced diagnostic tools to complement therapeutic strategies for osteoporosis and related bone diseases.

Related Experiment Videos